Los Angeles Capital Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-13,114
| Closed | -$489K | – | 1634 |
|
|
2021
Q2 | $489K | Sell |
13,114
-8,325
| -39% | -$310K | ﹤0.01% | 1173 |
|
|
2021
Q1 | $548K | Sell |
21,439
-27,115
| -56% | -$693K | ﹤0.01% | 1175 |
|
|
2020
Q4 | $1.07M | Sell |
48,554
-2,595
| -5% | -$57.2K | ﹤0.01% | 917 |
|
|
2020
Q3 | $920K | Sell |
51,149
-4,466
| -8% | -$80.3K | ﹤0.01% | 853 |
|
|
2020
Q2 | $1.41M | Sell |
55,615
-11,389
| -17% | -$289K | 0.01% | 719 |
|
|
2020
Q1 | $1.23M | Buy |
67,004
+42,312
| +171% | +$777K | 0.01% | 662 |
|
|
2019
Q4 | $544K | Buy |
24,692
+12,712
| +106% | +$280K | ﹤0.01% | 995 |
|
|
2019
Q3 | $172K | Hold |
11,980
| – | – | ﹤0.01% | 1219 |
|
|
2019
Q2 | $189K | Hold |
11,980
| – | – | ﹤0.01% | 1296 |
|
|
2019
Q1 | $176K | Buy |
+11,980
| New | +$176K | ﹤0.01% | 1321 |
|